Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 4 Interventional

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

ClinicalTrials.gov ID: NCT05433584

Public ClinicalTrials.gov record NCT05433584. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes

Study identification

NCT ID
NCT05433584
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
780 participants

Conditions and interventions

Interventions

  • Tirzepatide Drug
  • Antihyperglycemic medication Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2022
Primary completion
Oct 20, 2025
Completion
Oct 31, 2027
Last update posted
Dec 11, 2025

2022 – 2027

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
Cahaba Research - Trussville Birmingham Alabama 35235
San Fernando Valley Health Institute Canoga Park California 91304
Velocity Clinical Research, Huntington Park Huntington Park California 90255
Velocity Clinical Research, San Diego La Mesa California 91942
Clinical Trials Research Lincoln California 95648
Velocity Clinical Research, Westlake Los Angeles California 90057
Catalina Research Institute, LLC Montclair California 91763
Velocity Clinical Research, North Hollywood North Hollywood California 91606
Velocity Clinical Research, Panorama City Panorama City California 91402
Western University of Health Sciences Pomona California 91766
Velocity Clinical Research, Santa Ana Santa Ana California 92704
New England Research Associates, LLC Bridgeport Connecticut 06606
Excel Medical Clinical Trials Boca Raton Florida 33434
Alliance for Multispecialty Research, LLC Coral Gables Florida 33134
South Florida Clinical Research Institute Margate Florida 33063
Emory University School of Medicine- Grady Campus Atlanta Georgia 30303
Center for Advanced Research & Education Gainesville Georgia 30501
Qualmedica Research, LLC Evansville Indiana 47715
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
Qualmedica Research Bowling Green Kentucky 42101
NECCR PrimaCare Research Fall River Massachusetts 02721
SKY Integrative Medical Center/SKYCRNG Ridgeland Mississippi 39157
StudyMetrix Research City of Saint Peters Missouri 63303
Clinvest Research LLC Springfield Missouri 65807
Research Foundation of SUNY - University of Buffalo Buffalo New York 14221
Lucas Research, Inc Morehead City North Carolina 28557
The Corvallis Clinic, P.C. Corvallis Oregon 97330
Clinical Research of Philadelphia Philadelphia Pennsylvania 19114
Preferred Primary Care Physicians Uniontown Pennsylvania 15401
Tribe Clinical Research, LLC Greenville South Carolina 29607
Velocity Clinical Research, Spartanburg Spartanburg South Carolina 29303
Dallas Diabetes Research Center Dallas Texas 75230

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05433584, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2025 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05433584 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →